​​​​JEFFREY ADELGLASS, M.D., F.A.C.S.
​CLINICAL RESEARCH STUDIES
​Dallas | ft. worth TEXAS

​​​ currently enrolling subjects for
​PAID CLINICAL RESEARCH participation

Additional info about these two research studies (listed below):

Moving on From Migraine - Frequent migraines can stop you from living your life to its fullest. Preventing attacks could get you back to your usual activities.
Chronic (C-BEOND) Migraine Study:


A clinical research study called the C-BEOND Study is looking at whether abobotulinum toxin A injections can help to reduce or prevent the number of migraine attacks in adults with chronic migraine.


The C-BEOND Study is reruiting individuals who:

• Are aged at least 18 years

• Have been diagnosed with chronic migraine at least 12 months ago

• Started to have migraines before the age of 50 years

• Typically spend at least 15 days per month with a headache out of which at least 8 of these headache days are days with a migraine.


​Abobotulinum toxin A (Dysport®) is approved for a number of medical and cosmetic uses but not currently for migraine.


There are other criteria to meet in order to join the study, which the study team will discuss with you. Contacting us does not mean that you must join the study or that you will be able to participate.​

Do YOU suffer with 6 or more migraine days per month? If you began having migraines before age 50 and suffer with 6 or more episodes per month, you may qualify to participate in a paid migraine research study now enrolling at Research Your Health in Plano, Texas. Qualified adult participants 18 years and up will be compensated for study-related participation and travel to study center visits. Some Key Requirements for Participation (not a complete list): Regularly experience minimum of 6 migraines per month, Began having migraines before age 50, No CGRP agonist drug preventitive use: Nurtec(R) OTD, Ajovy(R), Aimovig(R), Vyepti(R), Emgality(R) within 12 weeks, maximum of 2 rescue uses, No opioid or barbituate use, No Botox(R) or other neurotoxin/neuromodulator treatments within 24 weeks. Call (972) 746-2222 to find out whether you qualify or visit researchyourhealth.com for more info. Get-On-the-List for other current and upcoming Research Your Health studies.

Moving on From Migraine - Frequent migraines can stop you from living your life to its fullest. Preventing attacks could get you back to your usual activities.

Episodic (E-BEOND) Migraine Study:


A clinical research study called the E-BEOND Study is looking at whether abobotulinum toxin A injections can help to reduce or prevent the number of migraine attacks in adults with episodic migraine.


The E-BEOND Study is reruiting individuals who:

• Are aged at least 18 years

• Have been diagnosed with migraine at least 12 months ago

• Started to have migraines before the age of 50 years

• Typically spend less than 15 days per month with a headache out of which at least 6 of these headache days are days with a migraine.


​Abobotulinum toxin A (Dysport®) is approved for a number of medical and cosmetic uses but not currently for migraine.


There are other criteria to meet in order to join the study, which the study team will discuss with you. Contacting us does not mean that you must join the study or that you will be able to participate.​


http://www.researchyourhealth.com/contact-us.html UA-62491137-11